Cell & Gene Therapy (CGT) Glossary

In CGT, every shipment matters — often to a patient’s life. That’s why we don’t just handle logistics — we understand the science behind it. From apheresis to cell delivery, our team ensures precision, compliance, and care every step of the way. 

We speak the language of CGT — so your therapies get where they need to go, safely and on time. 

Key Terms in CGT 

• Allogeneic: Cells sourced from a donor (not the patient). 

• Autologous: Cells sourced from the patient themselves. 

• Apheresis: A technique where whole blood is removed, separated into components, a specific component (e.g., white blood cells) is collected, and the rest returned to the individual. 

• Leukapheresis: apheresis in which the blood component collected is white blood cells 

• Starting Material: Another term for collected patient material (another word for apheresis or leukapheresis) 

• CAR-T (Chimeric Antigen Receptor T-cells): Genetically engineered T-cells designed to target and kill cancer cells. 

• T-cell: A type of white blood cell which plays a role in the body’s immune response 

• Treg Cell (Regulatory T-cell): Specialized subpopulation of T-cells that suppress the immune response 

• Multipotent Stem Cell: A stem cell capable of becoming a limited range of cell types (e.g., adult stem cells). 

• Pluripotent Stem Cell: A stem cell capable of becoming nearly any cell type in the body (e.g., embryonic stem cells). 

• CRISPR: A gene editing technology used to modify DNA with precision. 

• Vector: A biological tool used to deliver genetic material into cells 

We’ve built a quick glossary to break down key terms in Cell & Gene Therapy — but we know there’s always more to learn.

Related Contents: